164 related articles for article (PubMed ID: 3924606)
1. Prophylaxis of Pseudomonas aeruginosa infections in leukopenic mice by a combination of active and passive immunization.
Martinez D; Callahan LT
Eur J Clin Microbiol; 1985 Apr; 4(2):186-9. PubMed ID: 3924606
[TBL] [Abstract][Full Text] [Related]
2. Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.
Manafi A; Kohanteb J; Mehrabani D; Japoni A; Amini M; Naghmachi M; Zaghi AH; Khalili N
BMC Microbiol; 2009 Feb; 9():23. PubMed ID: 19183501
[TBL] [Abstract][Full Text] [Related]
3. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995
[TBL] [Abstract][Full Text] [Related]
4. Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids.
Pavlovskis OR; Edman DC; Leppla SH; Wretlind B; Lewis LR; Martin KE
Infect Immun; 1981 May; 32(2):681-9. PubMed ID: 6788700
[TBL] [Abstract][Full Text] [Related]
5. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa.
Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV
Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197
[TBL] [Abstract][Full Text] [Related]
6. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy.
Stanislavsky ES; Dmitriev BA; Lányi B; Joó I
Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389
[No Abstract] [Full Text] [Related]
7. Protection against exotoxin A (ETA) and Pseudomonas aeruginosa infection in mice with ETA-specific antipeptide antibodies.
El-Zaim HS; Chopra AK; Peterson JW; Vasil ML; Heggers JP
Infect Immun; 1998 Nov; 66(11):5551-4. PubMed ID: 9784572
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A.
Ohtsuka H; Horigome K; Ochi H; Nishimoto T; Kozuki T; Kato M; Okuda T; Noguchi H
Hybridoma; 1991 Apr; 10(2):297-307. PubMed ID: 1651902
[TBL] [Abstract][Full Text] [Related]
9. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A].
Brodinova NS; Vovk VA; Aleksandrov AD; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376
[TBL] [Abstract][Full Text] [Related]
10. Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.
Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1998 Apr; 47(4):295-301. PubMed ID: 9568994
[TBL] [Abstract][Full Text] [Related]
11. [Study of protective properties of recombinant atoxic form of exotoxin A and recombinant outer membrane protein F of Pseudomonas aeruginosa].
Mikhaĭlova NA; Vertiev IuV; Kaloshin AA; Isakov MA
Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):39-44. PubMed ID: 20464999
[TBL] [Abstract][Full Text] [Related]
12. Cloning, expression and characterization of recombinant exotoxin A-flagellin fusion protein as a new vaccine candidate against Pseudomonas aeruginosa infections.
Tanomand A; Farajnia S; Najar Peerayeh S; Majidi J
Iran Biomed J; 2013; 17(1):1-7. PubMed ID: 23279828
[TBL] [Abstract][Full Text] [Related]
13. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis.
Homma JY; Tanimoto H
Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783
[No Abstract] [Full Text] [Related]
14. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines?
Pier GB
Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204
[No Abstract] [Full Text] [Related]
15. Effect of passive immunotherapy on murine gut-derived sepsis caused by Pseudomonas aeruginosa.
Matsumoto T; Furuya N; Tateda K; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
J Med Microbiol; 1999 Aug; 48(8):765-770. PubMed ID: 10451000
[TBL] [Abstract][Full Text] [Related]
16. Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A.
Elzaim HS; Chopra AK; Peterson JW; Goodheart R; Heggers JP
Infect Immun; 1998 May; 66(5):2170-9. PubMed ID: 9573104
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers.
Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G
Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911
[No Abstract] [Full Text] [Related]
18. Prophylactic and therapeutic protection of human IgG purified from sera containing anti-exotoxin A titers against pneumonia caused by
Zhang J; Wan C; Yu B; Gao C; Zhao L; Cheng X; Yang F; Gu H; Zou Q; Gu J; Wang X
Hum Vaccin Immunother; 2019; 15(12):2993-3002. PubMed ID: 31116632
[TBL] [Abstract][Full Text] [Related]
19. [Immunobiological properties of recombinant atoxic forms of the Pseudomonas aeruginosa exotoxin A].
Isakov MA; Soldatenkova AS; Kaloshin AA; Mikhaĭlova NA
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):37-42. PubMed ID: 21598613
[TBL] [Abstract][Full Text] [Related]
20. Comparative immunochemistry of two fragments from domains Ib and III of Pseudomonas aeruginosa exotoxin A.
Rutault K; Vacheron MJ; Guinand M; Michel G
Infect Immun; 1993 Dec; 61(12):5417-20. PubMed ID: 8225617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
